An epigenetic model of cancer that incorporates the concept of stochasticity could also explain why cancer risk increases with age and how biological development can be reversible.
Academic rigour, journalistic flair
Articles on Oncology
Displaying 21 - 40 of 61 articles
While lung cancer rates have decreased by 43% in men, they have risen by 79% in women. New screening guidelines and recognizing early symptoms can help address the changing face of lung cancer.
Cancer cells are ‘cheaters’ that do not cooperate with the rest of the body. Certain microbes in your diet can either protect against or promote tumor formation by influencing cell cooperation.
Preventive and therapeutic vaccines both train the immune system to fight disease, but they are used in different ways.
Some cancers are notoriously resistant to chemotherapy and not curable with surgery. Stopping tumors from adapting to the harsh microenvironments of the body could be a potential treatment avenue.
Many tumors have cancer stem cells that help them grow and evade treatments. Differentiation therapy forces these cells to mature, stopping growth with less toxicity than traditional treatments.
Counterintuitively, cells move faster in thicker fluids. New research on breast cancer cells explains why, and reveals the role that fluid viscosity plays in metastasis.
Immunotherapy has the potential to eliminate tumors, but works best for select patients. Engineering T cells to bypass cancer’s defenses could help expand treatment eligibility to more patients.
One enzyme plays a key role in how tumor cells replicate and divide indefinitely. Identifying the genes that give these cells their immortality could provide new drug targets to treat cancer.
Multicancer early detection tests are among the priorities of the Biden administration’s Cancer Moonshot. The tests show promise, but questions remain about when and how to use them.
Both cancer and cancer treatment can impact someone’s ability to have biological children. It’s important to discuss fertility right after cancer diagnosis.
Since the war broke out, some healthcare workers have lost their jobs, others have been displaced, wounded, threatened or killed.
October is awash in seas of pink T-shirts, balloons and ribbons in honor of Breast Cancer Awareness Month. But this messaging fails to recognize people who are not cured of the disease.
The miracles of modern medicine can be life-saving. Yet as Tim Baker writes, cancer patients yearn for a little empathy from their doctors, as well as scripts.
Patients with blood cancer undergoing stem cell transplantation have a high risk of complications. The bacteria in their gut, however, can help their immune system recover and fight infections.
Early detection of breast cancer is critical to improving chances of survival. But racial and ethnic minority patients systematically have delayed diagnoses that reduce the benefits of screening.
One promising cancer treatment has been in the works for decades, but severe side effects have kept it out of the clinic. A reengineered version may offer a way to safely harness its potent effects.
Belonging to one or more groups with long-standing social and economic disadvantages increases the risk of cancer diagnoses and death.
Tumors contain thousands of genetic changes, but only a few are actually cancer-causing. A quicker way to identify these driver mutations could lead to more targeted cancer treatments.
The COVID-19 mRNA vaccines put nanomedicine in the spotlight as a potential way to treat diseases like cancer and HIV. While the field isn’t there yet, better design could help fulfill its promise.
Top contributors
-
Adjunct Professsor, School of Psychology, Faculty of Health and Medical Sciences, University of Adelaide
-
Associate Director of Community Outreach in Thoracic Oncology, University of Miami
-
Associate Professor of Pathology, Penn State
-
Assistant Professor of Biomedical Engineering, Binghamton University, State University of New York
-
Professor of Sociology, Ball State University
-
Associate Professor of Hematology and Oncology, Penn State
-
Professor of Biomedical Engineering, Johns Hopkins University
-
Associate Professor of Pathology, Penn State
-
Associate professor of medicine, Vanderbilt University
-
PhD Candidate in Anatomical Sciences, University of the Witwatersrand
-
Adjunct Clinical Associate Professor, AMREP Department of Medicine, Alfred Hospital, Melbourne & Senior Medical Oncologist and Palliative Care Physician, Melbourne Oncology Group, Cabrini Haematology and Oncology Centre, Wattletree Road, Malvern, Monash University
-
Postdoctoral associate, University of Florida
-
Senior research scientist, Queensland Institute of Medical Research
-
Associate Professor of Medicine, University of California, Los Angeles
-
Associate Professor of Medicine, Sydney Medical School, Concord Clinical School; Medical Oncologist, Concord Cancer Centre, University of Sydney
